Evan Ogburn is the founder and co-owner of PHARM CBD based in Bedford, KY, a company that specializes in the cultivation, processing and formulation of high-quality, contaminant-free healthcare products from high CBD hemp. Evan is certified by the US Society for Quality (ASQ) in pharmaceutical current Good Manufacturing Practices (cGMP) and quality systems auditing. Mr. Ogburn was a project manager and primary contributor assisting the Massachusetts Department of Public Health (MDPH) in refining and implementing their laboratory examination program, conducting audits, or laboratory examinations to evaluate laboratory compliance, and providing a Quality Assurance Program Plan and supporting technical procedures for the laboratory analysis and quality control of medical cannabis and cannabis products. He has years of hands-on, professional experience in hemp processing, final product formulation, laboratory operations, quality assurance/quality control and experimental design for the characterization and quantitation of ionic and nonionic organic compounds in cGMP and Good Laboratory Practices (GLP) regulated environments. Mr. Ogburn is an expert in analytical method development and validation in accordance with International Conference on Harmonization (ICH) and United States Pharmacopeia (USP) guidelines for multiple analytical techniques. He has performed and supervised these methodologies on a variety of projects, throughout all phases of the Investigational New Drug (IND), New Drug Application (NDA), and post-market evaluation phases (i.e. Phase 0 – Phase 4) for active pharmaceutical ingredients, drug products, drug delivery systems prior to getting into the hemp/medical marijuana industries.